PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Massachusetts General research team evolves CRISPR-Cas9 nucleases with novel properties

Engineered variants of gene-cutting enzyme double the targeting range and reduce off-target effects

2015-06-22
(Press-News.org) A team of Massachusetts General Hospital (MGH) researchers has found a way to expand the use and precision of the powerful gene-editing tools called CRISPR-Cas9 RNA-guided nucleases. In their report receiving advance online release in Nature, the investigators describe evolved versions of the DNA-cutting Cas9 enzyme that are able to recognize a different range of nucleic acid sequences than is possible with the naturally occurring form of Cas9 that has been used to date.

"In our paper we show that sites in human and zebrafish genes that could not previously be modified by wild-type Cas9 can now be targeted with the new variants we have engineered," says Benjamin Kleinstiver, PhD, a research fellow in the MGH Molecular Pathology Unit and lead author of the Nature paper. "This will allow researchers to target an expanded range of sites in a variety of genomes, which will be useful for applications requiring highly precise targeting of DNA sequences."

CRISPR-Cas9 nucleases consist of the Cas9 bacterial enzyme and a short, 20-nucleotide RNA molecule that matches the target DNA sequence. In addition to the RNA/DNA match, the Cas9 enzyme needs to recognize a specific nucleotide sequence called a protospacer adjacent motif (PAM) adjacent to the target DNA. The most commonly used form of Cas9, derived from the bacteria Streptococcus pyogenes and known as SpCas9, recognizes PAM sequences in which any nucleotide is followed by two guanine DNA bases. This limits the DNA sequences that can be targeted using SpCas9 only to those that include two sequential guanines.

To get around this limitation the MGH team set up an engineering system that allowed them to rapidly evolve the ability of SpCas9 to recognize different PAM sequences. From a collection of randomly mutated SpCas9 variants, they identified combinations of mutations that enabled SpCas9 to recognize new PAM sequences. These evolved variants essentially double the range of sites that can now be targeted for gene editing using SpCas9. Fortuitously, they also identified an SpCas9 variant that was less likely to induce the off-target gene mutations sometimes produced by CRISPR-Cas9 nucleases, a problem originally described in a 2013 study led by J. Keith Joung, MD, PhD, associate chief of Research in the MGH Department of Pathology and senior author of the current study. "This additional evolved variant with increased specificity should be immediately useful to all researchers who currently use wild-type SpCas9 and should reduce the frequencies of unwanted off-target mutations," Joung says.

"Perhaps more importantly," he adds, "our findings provide the first demonstration that the activities of SpCas9 can be altered by directed protein evolution. In fact, we show in our paper that the forms of Cas9 found in two other bacteria - Staphylococcus aureus and Streptococcus thermophilus - can also function in our bacterial evolution system, suggesting that we should be able to modify their functions as well. This work just scratches the surface of the range of PAMs that can be targeted by Cas9, and we believe that other useful properties of the enzyme may be modified by a similar approach, allowing potential customization of many important features." Joung is a professor of Pathology at Harvard Medical School.

INFORMATION:

Additional co-authors of the Nature paper are Michelle Prew, Shengdar Tsai, PhD, Ved Topkar, Nhu Nguyen, Zongli Zheng, PhD, and Martin Aryee, PhD, MGH Molecular Pathology Unit; and Andrew Gonzales, Zhuyun Li, Randall Peterson, PhD, and Jing-Ruey Joanna Yeh, PhD, MGH Cardiovascular Research Center. The study was supported by National Institutes of Health (NIH) Director's Pioneer Award DP1 GM105378, NIH grants R01 GM107427 and R01 GM088040, a Jim and Ann Orr Research Scholar Award, and a National Sciences and Engineering Research Council of Canada Postdoctoral Fellowship. The MGH has filed a patent application on the use of the SpCas9 variants described in this paper.

Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH conducts the largest hospital-based research program in the United States, with an annual research budget of more than $760 million and major research centers in AIDS, cardiovascular research, cancer, computational and integrative biology, cutaneous biology, human genetics, medical imaging, neurodegenerative disorders, regenerative medicine, reproductive biology, systems biology, transplantation biology and photomedicine.



ELSE PRESS RELEASES FROM THIS DATE:

No 'heckler's veto' in online ratings of doctors, UMD study shows

2015-06-22
COLLEGE PARK, Md. - Doctors have many concerns about online crowdsourced ratings, which are intended to make patients better-informed consumers of health care, but this is a big one: They worry that complainers will be the most outspoken contributors to rating sites, skewing scores and resulting in a kind of heckler's veto. A new study from the Robert H. Smith School of Business at the University of Maryland finds that that fear is unwarranted. Researchers compared the ratings of 1,425 doctors in three metropolitan areas -- Denver, Kansas City and Memphis -- on the popular ...

Best Practice Framework is good benchmarking tool for Fracture Liaison Services worldwide

2015-06-22
A new review by the International Osteoporosis Foundation (IOF) has confirmed the success of the Capture the Fracture®; Best Practice Framework as a single set of quality standards which can be used effectively to benchmark Fracture Liaison Services within a variety of health-care systems worldwide. Worldwide, osteoporosis causes more than 8.9 million fractures annually, resulting in an osteoporotic fracture every 3 seconds. Among those at highest risk of fractures are individuals who have already experienced a first fracture. Fracture Liaison Services, commonly ...

Heart patients can stop blood thinners when undergoing elective surgery

2015-06-22
DURHAM, N.C. - Patients with atrial fibrillation who stopped taking blood thinners before they had elective surgery had no higher risk of developing blood clots and less risk of major bleeding compared to patients who were given a "bridge" therapy, according to research led by Duke Medicine. The findings add much-needed clarity to inconsistent practice guidelines that annually affect an estimated 250,000 patients with atrial fibrillation/flutter who take the blood thinner warfarin. The Duke-led study was presented June 22, 2015, at the International Society on Thrombosis ...

Award-winning agent developed for prostate cancer diagnosis and treatment

2015-06-22
Prostate-specific membrane antigen (PSMA) is a surface protein that is normally present on healthy prostate cells, but is found at much higher levels on prostate cancer cells. It is barely found in the rest of the body. "Therefore, PSMA is an ideal target for diagnostic purposes as well as targeted therapies against prostate cancer," says biotechnologist Dr. Matthias Eder of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ). Eder's group has developed a small molecule (PSMA-617) that is capable of specifically attaching to PSMA and can be labeled ...

More women are reaching 100 but centenarian men are healthier

2015-06-22
New research conducted by a team at King's College London has found an increasing trend in the number of people in the UK reaching age 100 over the past two decades. The study also found that, whilst women were far more likely to reach 100 than men, males tended to be healthier and had fewer diagnosed chronic illnesses compared to women. The study, published today in the Journal of the American Geriatrics Society, used electronic health records to examine some of the main age-related chronic illnesses, including diabetes, stroke, arthritis and cancer, as well as old ...

Study could reduce unnecessary cancer screening

2015-06-22
A large clinical trial led by researchers at The Ottawa Hospital and the University of Ottawa has found that contrary to expectations, a CT scan of the abdomen and pelvis does not improve cancer detection in people with unexplained blood clots in their legs and lungs. The results, published in the June 22 edition of the New England Journal of Medicine, are expected to improve patient care and reduce screening costs around the world. More than 500,000 Canadians and Americans are diagnosed with blood clots in the lungs and legs each year (called venous thromboembolism). ...

Dartmouth-led study finds wolves are better hunters when monkeys are around

2015-06-22
Through a rare mixed-species association observed between a carnivorous predator and a potential prey, Dartmouth-led research has identified that solitary Ethiopian wolves will forage for rodents among grazing gelada monkey herds. Through consistent non-threatening behavior, the Ethiopian wolves have habituated gelada herds to their presence, foregoing opportunities to attack the juvenile geladas in order to better capture the rodents. Gelada monkeys are a close relative of baboons. As grazing primates, they eat grass and some herbs. They live in large herds, between ...

Soft core, hard shell -- the latest in nanotechnology

2015-06-22
Nanoparticles are the smallest particles capable of reaching virtually all parts of the body. Researchers use various approaches to test ways in which nanoparticles could be used in medicine - for instance, to deliver substances to a specific site in the body such as a tumor. For this purpose, nanoparticles are generally coated with organic materials because their surface quality plays a key role in determining further targets in the body. If they have a water-repellent shell, nanoparticles are quickly identified by the body's immune system and eliminated. How gold particles ...

MERS coronavirus: Candidate vaccine gears up for clinical trials

2015-06-22
Researchers from Ludwig-Maximilians-Universitaet (LMU) in Munich have demonstrated, in a preclinical setting, the protective effect of a candidate vaccine directed against the coronavirus that causes Middle East Respiratory Syndrome. Planning for the first clinical trial is now underway. Currently, no protective vaccine is available against the coronavirus strain responsible for Middle East Respiratory Syndrome (MERS). The need for such a vaccine is underlined by the current outbreak of the disease in South Korea, which has led to the infection of over 150 people and ...

If you demonstrate that 'black lives matter,' others will too

2015-06-22
UNIVERSITY OF CALIFORNIA, BERKELEY'S HAAS SCHOOL OF BUSINESS--The "Black Lives Matter" hashtag evolved as a call for social change aimed at increasing the conversation about racial inequality. But what if social change was less dependent on talking and more dependent on nonverbal communication? New research finds observing a white American engage in small nonverbal acts such as smiling more often, making eye contact for longer periods of time, and standing in closer proximity to a black American makes the observer less prone to racial biases. Specifically, small acts ...

LAST 30 PRESS RELEASES:

Populations overheat as major cities fail canopy goals: new research

By exerting “crowd control” over mouse cells, scientists make progress towards engineering tissues

First American Gastroenterological Association living guideline for moderate-to-severe ulcerative colitis

Labeling cell particles with barcodes

Groundwater pumping drives rapid sinking in California

Neuroscientists discover how the brain slows anxious breathing

New ion speed record holds potential for faster battery charging, biosensing

Haut.AI explores the potential of AI-enhanced fluorescence photography for non-invasive skin diagnostics

7-year study reveals plastic fragments from all over the globe are rising rapidly in the North Pacific Garbage Patch 

New theory reveals the shape of a single photon 

We could soon use AI to detect brain tumors

TAMEST recognizes Lyda Hill and Lyda Hill Philanthropies with Kay Bailey Hutchison Distinguished Service Award

Establishment of an immortalized red river hog blood-derived macrophage cell line

Neural networks: You might not need to buy every ticket to win the lottery

Healthy New Town: Revitalizing neighborhoods in the wake of aging populations

High exposure to everyday chemicals linked to asthma risk in children

How can brands address growing consumer scepticism?

New paradigm of quantum information technology revealed through light-matter interaction!

MSU researchers find trees acclimate to changing temperatures

World's first visual grading system developed to combat microplastic fashion pollution

Teenage truancy rates rise in English-speaking countries

Cholesterol is not the only lipid involved in trans fat-driven cardiovascular disease

Study: How can low-dose ketamine, a ‘lifesaving’ drug for major depression, alleviate symptoms within hours? UB research reveals how

New nasal vaccine shows promise in curbing whooping cough spread

Smarter blood tests from MSU researchers deliver faster diagnoses, improved outcomes

Q&A: A new medical AI model can help spot systemic disease by looking at a range of image types

For low-risk pregnancies, planned home births just as safe as birth center births, study shows

Leaner large language models could enable efficient local use on phones and laptops

‘Map of Life’ team wins $2 million prize for innovative rainforest tracking

Rise in pancreatic cancer cases among young adults may be overdiagnosis

[Press-News.org] Massachusetts General research team evolves CRISPR-Cas9 nucleases with novel properties
Engineered variants of gene-cutting enzyme double the targeting range and reduce off-target effects